Physician profile
Bindiya Patel
NPI 1841886587
$5,943.73
in general payments reported to CMS, 2019-2025
18 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,283 · 2022: $2,064 · 2023: $1,223 · 2024: $213 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,596.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,052.19 | 2021-2024 | Prolia, Evenity, Otezla |
| Biohaven Pharmaceuticals, INC. | $1,030.95 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $949.04 | 2021-2023 | Breztri, Farxiga, Lokelma |
| Novo Nordisk INC | $752.33 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $427.18 | 2021-2024 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $370.81 | 2022-2024 | |
| Pfizer INC. | $262.45 | 2021-2024 | |
| Glaxosmithkline, LLC. | $248.26 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $221.50 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $178.94 | 2022 | |
| Edwards Lifesciences Corporation | $160.01 | 2025 | Pascal |
| Exact Sciences Corporation | $89.50 | 2023-2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $69.30 | 2021-2023 | Steglatro, Belsomra, Gardasil 9 |
| Biohaven Pharmaceutical Holding Company LTD. | $50.80 | 2022 | |
| Abbott Laboratories | $31.73 | 2024 | Freestyle Libre 3 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $20.44 | 2024 | Mild Device Kit |
| Amarin Pharma, INC. | $15.28 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bindiya Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.